European bronchitis treatment market is projected to witness considerable growth during the forecast period. Significant rise in the prevalence of asthma is the major factor contributing to the demand for bronchitis treatment in the country. Considerable increasing healthcare spending and rise in ageing population are some crucial factors significantly increased the demand for bronchitis treatment in the region. Moreover, it has been estimated by Health and Safety Executive that about 15% of the total respiratory diseases are diagnosed in the people working at dusty workplace. Regarding this, the Government of UK had launched surveillance of work-related and occupational respiratory disease (SWORD) scheme. About 420 physicians report regarding the workplace respiratory diseases among the employees. This is offering growth to the bronchitis treatment market in European region.
To Request a Sample of our Report on European Bronchitis Treatment Market: https://www.omrglobal.com/request-sample/europe-bronchitis-treatment-market
European bronchitis treatment market is classified on the basis of type of treatment, which includes drugs and oxygen therapy. The drugs segment is further segregated into antibiotics, anti-inflammatory drugs, bronchodilators, and others. Among these types of treatments, the drugs find its significant application in the bronchitis treatment across the globe. In addition, the bronchodilator is estimated to project a considerable CAGR during the forecast period. Bronchodilators are the first-line medication used to treatment of bronchitis, to clear the airway obstruction, which is considered as first-step in chronic bronchitis to ease breathing problems.
Geographically, European bronchitis treatment market is segmented into Germany, UK, France, Italy, Spain, and rest of Europe. UK contributed the significant share in the European bronchitis treatment market. The growth is owing to the various healthcare facilities and well-developed healthcare infrastructure. Germany and France have a world-class healthcare system providing a stable platform for the growth of the bronchitis treatment market in the respective countries. Apart from the major European countries, Switzerland, the Netherlands, Denmark, Norway Ireland, Hungary, and Belgium are some other countries of Europe that are providing a significant contribution to the growth of the bronchitis treatment market.
A full Report of European Bronchitis Treatment Market is Available at: https://www.omrglobal.com/industry-reports/europe-bronchitis-treatment-market
European Bronchitis Treatment Market – Segmentation
By Technology
- Medication
- Antibiotics
- Anti-inflammatory drugs
- Bronchodilators
- Others (Mucolytics)
- Oxygen Therapy
European Bronchitis Treatment Market – Segmentation by Geography
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Abbott Laboratories
- Bayer AG
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- GlaxoSmithKline PLC
- Lupin Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd.
Reasons to Buy From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/europe-bronchitis-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
